For research use only. Not for therapeutic Use.
BLXA-4 (Cat.No:I004347) is a drug potentially for the treatment of gingival diseases.
| Catalog Number | I004347 |
| CAS Number | 362516-29-8 |
| Synonyms | BLXA-4; BLXA-4-ME; BLXA-4 ME; BLXA4; BLXA4ME; BLXA 4; BLXA 4 ME;methyl (5S,6R,E)-5,6-dihydroxy-8-(2-((R,E)-3-hydroxyoct-1-en-1-yl)phenyl)oct-7-enoate |
| Molecular Formula | C23H34O5 |
| Purity | ≥95% |
| Solubility | Soluble in DMSO |
| Storage | 0 - 4 °C for short term or -20 °C for long term |
| IUPAC Name | methyl (E,5S,6R)-5,6-dihydroxy-8-[2-[(E,3R)-3-hydroxyoct-1-enyl]phenyl]oct-7-enoate |
| InChI | InChI=1S/C23H34O5/c1-3-4-5-11-20(24)16-14-18-9-6-7-10-19(18)15-17-22(26)21(25)12-8-13-23(27)28-2/h6-7,9-10,14-17,20-22,24-26H,3-5,8,11-13H2,1-2H3/b16-14+,17-15+/t20-,21+,22-/m1/s1 |
| InChIKey | CHUQDPKHYXGMEB-IQOAYPBESA-N |
| SMILES | CCCCCC(C=CC1=CC=CC=C1C=CC(C(CCCC(=O)OC)O)O)O |
| Reference | </br>1: Van Dyke TE, Hasturk H, Kantarci A, Freire MO, Nguyen D, Dalli J, Serhan CN. Proresolving nanomedicines activate bone regeneration in periodontitis. J Dent Res. 2015 Jan;94(1):148-56. doi: 10.1177/0022034514557331. PubMed PMID: 25389003; PubMed Ce |
